Bolt Biotherapeutics, Inc. (BOLT) vs Lexaria Bioscience Corp. (LEXX)
Bolt Biotherapeutics, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Lexaria Bioscience Corp. are of similar size ($7.1M and $6.9M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against 9.08%. Lexaria Bioscience Corp. has the higher net margin (0.00% vs −611.5%) and the lower return on invested capital (−662.6% vs −143.8%). Across the 17 metrics below, Bolt Biotherapeutics, Inc. leads on 9 and Lexaria Bioscience Corp. on 8.
Valuation
Profitability
| Metric | BOLT | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (654.53%) | 0.00% | 0.00% |
| Net margin | (611.47%) | 0.00% | 0.00% |
| Free cash flow margin | (655.72%) | 0.00% | 0.00% |
| Return on equity | (111.65%) | (162.60%) | (57.72%) |
| Return on assets | (49.62%) | (134.20%) | (49.22%) |
| Return on invested capital | (143.75%) | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack